Dr. Elizabeth (Liz) Stoner is currently Senior Clinical Advisor of AlloVir, an ElevateBio company, and most recently served as the company’s interim CMO. A distinguished biopharma executive, Liz is an MPM Executive Partner who brings decades of international industry experience to her role guiding and growing MPM’s and its affiliated portfolio companies, like AlloVir. In this capacity she is also a Senior Clinical Advisor to Rhythm Pharmaceuticals.
Liz has held several leadership roles at MPM portfolio companies including interim CEO of Semma Therapeutics; founder, CMO and Chief Development Officer (CDO) of Rhythm and the CDO of Vascular Pharmaceuticals. She also served in clinical and advisory roles at Clinical Ink, Potenza Therapeutics, Solasia and TriNetX. Lizis a member of the Cures Acceleration Network Review Board of the National Center for Advisory Translations Sciences of the NIH to represent viewpoints of drug development and venture capital professionals regarding the discovery and development of therapeutics, diagnostics and devices.
Prior to joining MPM, Liz was Senior Vice President of Global Clinical Development Operations atMerck Research Laboratories where she was responsible for its clinical development activities in more than 40 countries. While at Merck, she also oversaw the clinical development activities of its Japanese subsidiary and played a leading role in Merck/Schering Plough Joint Venture’s development of Vytorin and Zetia, blockbuster cholesterol lowering drugs. Previously, she led the 5-alpha reductase clinical development program, establishing Merck as a leader in the field of prostate disease. As Endocrine Therapeutic Head at Merck, her responsibilities included all steroid and lipid metabolism, as well as the bisphosphonate and growth hormone secretagogue clinical research programs. Prior to joining the biopharma industry, she was an AssistantProfessor of Pediatrics at Cornell University Medical College. Liz currently serves on the boards of Vascular Pharmaceuticals and Momenta Pharmaceuticals.She is also a member of the Albert Einstein College of Medicine Board ofGovernors, and the Weill Cornell Medical College Clinical and TranslationalScience Center External Advisory Board.
Liz received her M.D. from the Albert Einstein College of Medicine, her M.S. in Chemistry from SUNY at Stony Brook and her B.S. in Chemistry from Ottawa University, KS.